First Trust Nasdaq Pharmaceuticals ETF (FTXH) closed at $41.56 (+0.68%) on Sep 24, 2026. Its latest daily candle is a bullish harami. Price is above its 50-day and above its 200-day moving average. RSI(14) 55, RS Rating 87, -2.8% from its 52-week high, +25.5% year to date.
FTXH·$41.56+0.68%
ResistanceSupportVol 14
63 bars
StockSetups
37383940414243
Vol MA14 75.95K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
First Trust Nasdaq Pharmaceuticals ETF
Price41.56
Change+0.68%
Gap+0.51%
Rel volume—
Avg volume85.85K
Avg $ vol3.57M
SMA 2041.29
SMA 5040.45
SMA 20036.04
Price vs 50+2.76%
Price vs 200+15.30%
MA stackbullish
50/200 cross—
Supertrendup · 40.24
RSI (14)55
MACD hist-0.03
MACD cross—
Stoch %K / %D75 / 65
ADX (14)24
+DI / −DI28 / 17
RSI divergence—
MACD divergence—
ATR %1.46%
ADR %1.16%
52w high42.76
52w low27.30
From 52w high-2.81%
Above 52w low+52.23%
New 52w highNo
SqueezeOff
Bollinger width5.10%
%B0.63
Donchian pos59.32%
Donchian high42.40
Donchian low40.34
AVWAP (52w high)40.24
vs AVWAP high+3.27%
AVWAP (52w low)39.96
vs AVWAP low+4.02%
OBV trendFlat
Chaikin MF (20)0.06
Today vs 20d—
Avg vol (14d)75.95K
Avg vol (20d)85.85K
Avg $ vol (20d)3.57M
Market cap—
RS Rating87 / 99
RS 3m (vs SPY)+7.46%
RS 6m (vs SPY)+6.08%
RS line new highNo
Trend template8/8
Technical rank80.9
1 week+0.40%
1 month-2.81%
3 months+11.95%
6 months+22.89%
1 year+47.93%
YTD+25.47%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value—
Revenue—
Net income—
Gross profit—
Free cash flow—
Industry—
ExchangeXNAS
Shares out950K
Employees—
ListedTue, Sep 20, 2016
Free float—
Float %—
Short interest134.46K
Days to cover1.0d
Short volume75.2%
Squeeze score42 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction77 / 100
Pattern quality—
Tech rank80.9 / 100
Group rank—
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish harami
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.